Catheter Precision Schedules Special Meeting for Stockholders
Catheter Precision, Inc. (VTAK - NYSE/American), a leading medical device company based in the United States, is dedicated to revolutionizing the cardiac electrophysiology market. On the horizon is an important event for stockholders. The company has announced that September 10, 2025, will be recognized as the Record Date for their Special Meeting, which is set for October 10, 2025.
Key Agenda Items for Stockholders Meeting
This Special Meeting holds significance as it seeks to obtain stockholder approval for a few crucial matters. One fundamental proposal is an amendment to increase the authorized shares of common stock. This strategic decision is intended to position the company for future growth and expansion in an increasingly competitive market. Additionally, Catheter Precision plans to appoint WithumSmith+Brown, PC as their independent auditor for the fiscal year 2026, ensuring that they maintain high standards of financial integrity and transparency.
Anticipated Filing with SEC
As we prepare for this important meeting, additional details will be made available through a preliminary proxy statement anticipated to be filed with the SEC. This will give stockholders further insights into the discussions and resolutions that will be put forth during the meeting.
About Catheter Precision
Catheter Precision is not just another medical device company; it embodies innovation in the cardiac arrhythmia treatment landscape. The firm is committed to enhancing medical outcomes through advanced technology and collaboration with healthcare professionals. By continuously advancing its product offerings, the company aims to set new benchmarks in the electrophysiology space.
Innovations in Electrophysiology
The company's relentless passion for innovation drives its efforts to improve the lives of patients with cardiac issues. Their focus on developing advanced solutions reflects their dedication to addressing the specific needs of electrophysiology procedures, marking a significant advancement in treating cardiac arrhythmias.
Understanding Forward-Looking Statements
As a publicly traded company, Catheter Precision communicates through various formats, including press releases and public filings, which may contain forward-looking statements. However, it's important for investors and stakeholders to recognize that these statements often involve risks and uncertainties. Factors like market developments and changes in plans may affect the actual outcomes compared to what has been anticipated.
Important Legal Notices
Potential investors and current stockholders should remain informed about the filings related to the upcoming special meeting. The company plans to file proxy materials in connection with soliciting proxies for their meeting. Interested parties will have the ability to access these materials at no cost when released.
Staying Connected with Catheter Precision
For those interested in learning more about Catheter Precision and its endeavors, the company encourages stockholders and potential investors to stay engaged. By following their updates and participating in upcoming meetings, stakeholders can gain deeper insights into the company’s strategic direction.
Contact Information
For inquiries or further information, the Investor Relations team can be reached directly at 973-691-2000. Alternatively, you can send emails to their designated contact at IR@catheterprecision.com. This ensures that any queries regarding the company or its activities can be addressed efficiently.
Frequently Asked Questions
What is the purpose of the upcoming Special Meeting?
The Special Meeting aims to obtain stockholder approval for increasing authorized shares of common stock and appointing an independent auditor.
What date is scheduled for the record of stockholders?
The record date for stockholders is set for September 10, 2025.
Who is Catheter Precision?
Catheter Precision is a medical device company focused on developing innovative solutions for treating cardiac arrhythmias.
How can I stay informed about Catheter Precision's updates?
Stockholders can stay informed by following the company's communications and participating in meetings.
How can I contact Catheter Precision for more information?
Interested parties can contact the Investor Relations team at 973-691-2000 or via email at IR@catheterprecision.com.
